Close Menu

NEW YORK (GenomeWeb) – Quanterix said today it has entered a collaboration with Destina Genomics to explore the use of Quanterix's Simoa technology for the detection of microRNAs.

The effort will focus initially on development of an assay for detection and quantification of the liver toxicity biomarker microRNA-122.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.